NeoSlim AKG

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.88.003.Е.001859.04.17
Date of registration and renewal:18.04.2017
Dosage form: & nbsp415 mg capsules
Classification "Composition" & nbsp BAD - vitamin and mineral complexes
Classification "Clinical" & nbsp Supplements containing zinc, copper, manganese Supplements containing iron Supplements containing chromium Supplements containing selenium
Composition: & nbspCinnamon root extract, vitamin-mineral premix "Neo Slim" (zinc citrate, iron sulfate, tocopherol acetate, nicotinamide, manganese aspartate, calcium pantothenate, retinol acetate, copper sulfate, pyridoxine hydrochloride, riboflavin, thiamine hydrochloride, chromium picolinate, folic acid , selenite sodium, biotin, lactose monohydrate crystal), E460 or lactose monohydrate microcrystalline, E551, capsule shell (gelatin or E464, food color E171 or E100 or E101 or E160a or E162 or E163 or E140 or E141 , or E 132), the composition of capsules of the DRcapsTM capsule (E464, E418, food color E171, or E100, or E101, or E160a, or E162, or E163, or E140, or E141, or E 132).
Scope: & nbspFor the realization of a supplementary source of mineral substances (iron, copper, manganese, zinc, selenium, chromium), vitamins (A, E, B1, B2, B5, B6, nicotinamide (vitamin B3), folic acid, biotin.
Suggested Usage: & nbspAdults take 1-2 capsules 3 times a day, 20-30 minutes before meals, with a glass of water. Duration of admission is 4-6 weeks.If necessary, the reception can be repeated. Repeated receptions are possible throughout the year.
Contraindications:Individual intolerance to the components of the product, pregnancy and lactation. Before use, it is recommended to consult a doctor.
Shelf life:2 years.
Storage conditions:Store in a dry and inaccessible place for children at a temperature not exceeding + 25 ° C.
Research protocols:Expert conclusion of the FBUC of the Federal Target Program and the Federal Service for Consumer Rights Protection No. 10-2FTS / 1097 of 14.04.2017.
Recipient:Pharmaceutical holding GI EL Medical, OOOPharmaceutical holding GI EL Medical, OOO Russian Federation
Information update date: & nbsp25.06.2017
Instructions
Up